LDHB

Across TCGA pan-cancer cohorts, LDHB mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LDHB’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where LDHB mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types LDHB is over-expressed in tumor, although a few such as CCRCC and PDAC show the opposite, repressed pattern.

CCRCC, PDAC, and COAD are the cancer types where LDHB tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LDHB mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	IV	−0.843	<.001	12	view →
PDAC	Male	All	−0.858	<.001	11	view →
COAD	Male	II,III,IV	−0.467	<.001	9	view →
HNSC	All	II,III,IV	−0.245	.004	7	view →
LSCC	Male	III,IV	+0.253	.012	6	view →
LUAD	All	All	+0.122	.016	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LDHB–CCRCC

Open the CCRCC breakdown →